…to infinity and beyond! 
For years manufacturers and distributors have searched for the holy grail of DEA compliance – specific guidance from DEA on what actually constitutes a suspicious order. The obvious source of assistance and the sole legal basis establishing the requirement to detect and report suspicious orders is found in DEA’s own regulations.
DEA Compliance Programs
Do you see what DEA sees? The Controlled Substances Act and the DEA’s regulations are unambiguous and DEA’s interactions with registrants are predictable, right? Well, not always. However, the maze of DEA compliance issues can be made a little less complex by understanding the Agency’s perspective on issues. In the DEA Chronicles you will find
2012 DEA Enforcement Actions: A Year in Review
While the Drug Enforcement Administration (“DEA”) prosecuted far fewer administrative actions in FY2012 than FY2011, the Agency nonetheless continued to be very active in investigating pharmaceutical diversion cases. The highly publicized and unprecedented actions taken by DEA in FY2012 provide valuable insight to where the DEA may focus its enforcement efforts in 2013. The “DEA